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Grasp55−/− mice display impaired fat absorption
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The Golgi apparatus plays a central role in the intracellular transport of macromolecules.
However, molecular mechanisms of Golgi-mediated lipid transport remain poorly understood.
Here, we show that genetic inactivation of the Golgi-resident protein GRASP55 in mice
reduces whole-body fat mass via impaired intestinal fat absorption and evokes resistance to
high-fat diet induced body weight gain. Mechanistic analyses reveal that GRASP55 partici-
pates in the Golgi-mediated lipid droplet (LD) targeting of some LD-associated lipases, such
as ATGL and MGL, which is required for sustained lipid supply for chylomicron assembly and
secretion. Consequently, GRASP55 deficiency leads to reduced chylomicron secretion and
abnormally large LD formation in intestinal epithelial cells upon exogenous lipid challenge.
Notably, deletion of dGrasp in Drosophila causes similar defects of lipid accumulation in the
midgut. These results highlight the importance of the Golgi complex in cellular lipid regula-
tion, which is evolutionary conserved, and uncover potential therapeutic targets for obesity-
associated diseases.
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Many transport vesicles containing diverse proteins andlipids travel through the endoplasmic reticulum (ER)-to-Golgi trafficking pathway. The cargo proteins and
lipids then subsequently move to their final destinations,
including the plasma membrane. Since the discovery of the Golgi
body over 120 years ago, its function has been studied mostly
from a protein-centric viewpoint1,2. However, a growing body of
evidence suggests that the Golgi is also indispensable for reg-
ulation of cellular lipids and, in particular, plays an important role
in the cellular control of lipid storage and transport3,4. It is well
known that apolipoprotein B (APOB)-containing lipoproteins,
such as chylomicrons in the intestinal epithelium and very-low-
density lipoproteins (VLDLs) in hepatocytes, exit the cell via the
classical ER-to-Golgi secretory vesicular pathways5,6. Further-
more, knowledge accumulated over the last two decades has
identified some molecular machineries that are involved in the
trafficking and lipidation of APOB-containing lipoproteins dur-
ing their passage through the Golgi7,8. For example, microsomal
triglyceride transfer protein (MTP) has been shown to localize to
the Golgi and contribute to the maturation of APOB-containing
lipoproteins9. However, most mechanisms underlying Golgi-
mediated lipid transport pathways are not well defined.
The Golgi reassembly-stacking proteins (GRASPs/GORASPs)
were initially identified in vitro as factors required for the stacking
of Golgi cisternae10,11. However, later studies indicated that
GRASPs are largely dispensable for Golgi-mediated conventional
anterograde protein transport12. Instead, the extra-Golgi GRASPs
under cellular stress conditions have been implicated in uncon-
ventional protein secretion pathways of diverse cargos that bypass
the Golgi13,14. Two isoforms of GRASP have been identified in
vertebrates, GRASP65/GORASP1 and GRASP55/GORASP2, and
a recent report suggested that ablation of Grasp65 in mice did not
result in phenotypic defects15. In addition, the phenotype of
Grasp55 knockout mice has not been studied in detail, with the
exception of spermatogenesis defects and male infertility16.
Therefore, the physiological roles of GRASPs remain largely
elusive.
Here, through an integrated analysis in mouse, fly, and in vitro
systems, we demonstrate that the Golgi-resident protein
GRASP55 plays a crucial role in lipid homeostasis. We find that
genetic inactivation of GRASP55 in mice reduces whole-body fat
mass via impaired intestinal fat absorption. In the mouse intes-
tine, GRASP55 deficiency leads to reduced chylomicron secretion
and abnormally large lipid droplet (LD) formation in response to
exogenous lipid challenge, which is associated with failure of
Golgi-mediated LD targeting of some lipases, such as adipose
triglyceride lipase (ATGL) and monoglyceride lipase (MGL). The
lipid absorption and accumulation defects induced by GRASP55
deficiency are rescued by the supplementation of GRASP55 in
mice. Moreover, loss of dGRASP, the single Drosophila GRASP
homolog, causes similar defects of lipid accumulation in the
Drosophila midgut and these defects are rescued by the supple-
mentation of dGRASP or BMM, a Drosophila homolog of
mammalian ATGL17. Our data indicate that GRASP55 plays an
essential role in intestinal fat absorption in live animals. In
addition, these results suggest that GRASP55 is critical for Golgi-
mediated LD targeting of key LD regulating proteins and high-
light the importance of the Golgi complex in cellular lipid
regulation.
Results
Grasp55−/− mice display reduced fat mass and resistance to
high-fat diet-induced obesity. To study the physiological role of
GRASP55, the Grasp55 gene in mouse was inactivated by repla-
cing all exons with a neomycin expression cassette (Fig. 1a;
Supplementary Fig. 1a, b) and the absence of GRASP55 protein in
multiple tissues was confirmed by immunoblotting (Fig. 1b). Mice
lacking Grasp55 (Grasp55−/−) did not exhibit significant devia-
tion from the expected genotype distribution at birth (Supple-
mentary Table 1), or in survival at up to 40 weeks of age (Fig. 1c).
However, Grasp55−/− mice showed no weight gain after
approximately 12 weeks of age when fed on a normal diet
(Fig. 1d, e; Supplementary Fig. 1c, d). Examination of relative
organ weights revealed that white adipose tissue (Supplementary
Table 2) and body fat mass (Fig. 1f) were profoundly reduced in
Grasp55−/− mice. Moreover, the organ weight and cell size of
white (Fig. 1g–j) and brown (Supplementary Fig. 2) adipose tis-
sues were decreased because of collapsed cellular lipid depots.
Plasma levels of lipids, such as triglycerides (TGs) and total
cholesterols, were significantly reduced in Grasp55−/− mice
without affecting plasma protein levels (Supplementary Table 3).
Thus, the absence of GRASP55 in mice caused defects in body
lipid accumulation. Of note, Grasp55−/− mice displayed resis-
tance to a high-fat (60 cal% of fat, composition shown in Sup-
plementary Table 4) diet-induced weight gain (Fig. 1e) and body
fat mass increase (Fig. 1f). Moreover, gross and microscopic
analyses of epididymal white adipose tissue (EWAT) indicated
that GRASP55 deficiency profoundly inhibited the high-fat diet-
induced EWAT mass increase (Fig. 1g, h) and fat cell hyper-
trophy (Fig. 1i, j).
Grasp55 deletion did not alter total energy intake (Fig. 2a),
but reduced total energy expenditure (Fig. 2b). Considering the
reduced energy expenditure and normal dietary food intake, the
low body weights of Grasp55−/− mice (Fig. 1e) imply that
Grasp55−/− mice may suffer from impaired energy absorption.
Interestingly, the reduced energy expenditure of Grasp55−/−
mice was significantly restored in mice fed the high-fat diet
(Fig. 2b, inset). A recent report suggested that deletion of
dGrasp affected adipocyte lipid storage in fly due to defects in
dGRASP-mediated unconventional secretion of Upd2, a func-
tional homolog of human leptin, which resulted in decreased
Upd2-mediated insulin secretion18. Therefore, we measured
plasma leptin and insulin levels in Grasp55−/− mice. Plasma
leptin levels were significantly reduced in Grasp55−/− mice
under both fasting and postprandial conditions (Fig. 2c).
However, when the postprandial leptin levels were normalized
to body fat mass (Fig. 1f), leptin levels were comparable
between wild-type (WT, Grasp55+/+) and Grasp55−/− mice
(Fig. 2d; see the “Discussion” section). Plasma insulin levels
were reduced in Grasp55−/− mice (Fig. 2e), whereas plasma
glucose levels were not significantly altered by Grasp55 ablation
(Fig. 2f). Furthermore, results of an insulin tolerance test
indicated that insulin sensitivity of Grasp55−/− mice was
significantly increased (Fig. 2g). Collectively, these results imply
that Grasp55 deletion alters plasma levels of leptin and insulin
secondarily to reduction in body fat mass and improved insulin
sensitivity, suggesting that mechanisms other than reduced
secretion of leptin and insulin would be primarily responsible
for the lipid storage defects in Grasp55−/− mice.
GRASP55 is required for intestinal fat absorption and chylo-
micron secretion. An important clue to understand the
mechanism of the lipid storage defect observed in Grasp55−/−
mice was obtained via morphological examination of the intes-
tines. In contrast to that of adipocytes, lipid storage of intestinal
epithelial cells was markedly increased in Grasp55−/− mice,
especially after olive oil feeding (Fig. 3a–d), showing supersized
LDs in electron-microscopic (EM) images (Fig. 3e, f). These
results imply that intestinal dietary lipid handling is differently
affected by Grasp55 deletion.
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Dietary lipids, principally TGs, are hydrolyzed within the small
intestine to fatty acids (FAs) and 2-monoacylglycerol (MAG) by
intraluminal lipases. After uptake across the apical membrane,
FAs and MAG are re-esterified into TGs by acyltransferases in
enterocytes8. Enterocytes then complete the absorption process
by secreting the lipids across the basolateral membrane,
predominantly in the form of chylomicrons, which are the main
contributors to the postprandial serum lipid levels19. Interest-
ingly, ultrastructural analyses indicated that deficiency of
GRASP55 led to fewer chylomicrons in intestinal epithelial cells
prepared 2 h after oil bolus (Fig. 3g, h), suggesting reduced
chylomicron secretion. A chylomicron is composed of a core of
neutral lipids, mostly TGs with traces of cholesteryl ester, and a
shell of amphipathic lipids of phospholipids and cholesterol. They
are coated with and stabilized by the structural protein
apolipoprotein B (APOB)8. Examination of APOB blood levels
revealed that APOB levels were significantly reduced in Grasp55−/−
mice without affecting its protein levels in the jejunum (Supple-
mentary Fig. 3), further supporting the possibility of reduced
chylomicron secretion in the absence of GRASP55.
We then examined the effects of GRASP55 deficiency on
intestinal lipid absorption. The oral fat tolerance test in the
presence of tyloxapol, which inhibits lipoprotein catabolism,
showed that dietary TG absorption was strongly reduced in
Grasp55−/− mice (Fig. 4a), implying that GRASP55 depletion
inhibits chylomicron secretion from the intestines. An oral fat
tolerance test in the absence of tyloxapol also indicated that
GRASP55 deficiency evoked reductions in postprandial plasma
TG levels (Supplementary Fig. 4a). However, there were no
significant differences in the absorption of amino acids between
WT and Grasp55−/− mice (Supplementary Fig. 4b–d), indicating
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Fig. 1 Grasp55−/− mice display reduced fat mass and resistance to high-fat diet-induced obesity. a Knockout strategy for the Grasp55 locus. The
reporter-neo cassette replaced all 11 exons of mouse Grasp55. Red triangles indicate the location of loxP sites. More detailed diagrams are provided in the
Supplementary Fig. 1. b Expressions of GRASP55 and GRASP65 in major organs were examined by immunoblotting. The amount of β-actin protein was
monitored as a cytosolic protein loading control. c Survival curves of wild-type (Grasp55+/+) and Grasp55−/− male mice over 40 weeks (n= 15).
d Photographs of Grasp55+/+ and Grasp55−/− mice at postnatal day 28. e Body weight curves of male mice fed normal diet (ND, left) and high-fat diet
(HFD, right) at 1–30 weeks of age (n= 15). The arrow indicates the initiation time of HFD at 6 weeks of age. The body weight curve of the Grasp55+/+ mice
fed ND was replotted in the HFD graph (open circle, right) for comparison. f The relative fat mass ratio (fat/body weight) of 16-week-old male mice fed ND
and after HFD for 4 weeks (n= 5–7). g–j Gross and histological examinations of epididymal white adipose tissue (EWAT). Ventral view (g) and wet
weights (h) of EWAT (right side) of male mice at 18 weeks of age fed on ND and after HFD for 12 weeks (n= 6). Arrows indicate epididymal fat tissues.
Representative light microscopic tissue images (H&E staining) are presented in (i). Quantitative analyses of the H&E images, that inversely correlate with
fat contents of EWAT by counting the number of adipocyte nuclei in a light microscopic field (450 × 340 μm), are depicted in (j, n= 10). Unprocessed
blots are presented in Supplementary Fig. 22. Data are shown as mean ± SEM. Scale bars: 50 μm. **p < 0.01. All p values were calculated by unpaired two-
tailed Student’s t tests. Source data are provided as a Source Data file.
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deficiency. The decrease in lipid absorption of Grasp55−/− mice
was also identifiable by reduced turbidity of blood plasma lipid
suspensions collected 2 h after intragastric olive oil administration
(Fig. 4b). Notably, fractionation analysis of plasma lipids revealed
decreased TG (Fig. 4c, d) and cholesterol (Supplementary Fig. 5)
content in the chylomicron/VLDL fraction of blood samples from
Grasp55−/− mice obtained 2 h after the oil bolus, further
suggesting that GRASP55 depletion inhibits chylomicron secre-
tion. In addition, in vitro experiments with differentiated Caco-2
cells of human intestine origin demonstrated that GRASP55
depletion inhibited transepithelial lipid absorption (shGRASP55;
Fig. 4e–g). Notably, these defects were rescued by exogenous
GRASP55 supplementation (GRASP55-Myc; Fig. 4e–g).
GRASP55 participates in LD targeting of ATGL and MGL. We
next explored the mechanisms that might underlie the reduced
chylomicron secretion and increased LD size caused by GRASP55
deficiency in the mouse jejunum. GRASP55 participates in Golgi
stacking and ribbon linking as an adhesive peripheral Golgi
membrane protein20. We therefore investigated whether struc-
tural abnormalities in the Golgi cisternae were responsible for the
impairment of lipid transport. Although some Golgi membranes
appeared to have lost their characteristic flattened cisternae, the
GRASP55 deficiency alone did not cause Golgi unstacking
(Supplementary Fig. 6), which is consistent with a previous
in vitro analysis21. In addition, the deficiency of GRASP55 did
not affect protein expression levels (Supplementary Fig. 7a, b) or
perinuclear Golgi localization of other Golgi cisternal adhesive
proteins (Supplementary Fig. 7c), such as GM130, Golgin97,
GRASP65, and Golgin45, in the mouse jejunum.
To investigate whether GRASP55 deficiency affects the
intracellular trafficking of proteins involved in lipid metabolism,
we examined changes in the subcellular localization of apolipo-
proteins (APOB, APOA1, APOA4), regulatory proteins known to
be involved in assembly of chylomicrons (ARF1, ARFRP1,
CIDEB, GBF1, MTP)22–24, and LD-associated proteins and
lipases (ADPN, ATGL, CGI58, CES1, CES3, AADAC, MGAT2,
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Fig. 2 Metabolic profiles of Grasp55−/− mice. a, b Analyses of energy intake (a) and energy expenditure (b) were conducted in 12-week-old Grasp55+/+
and Grasp55−/− mice fed normal diet (ND) or high-fat diet (HFD). Energy expenditure differences between Grasp55+/+ and Grasp55−/− mice are plotted in
(b inset). Data are shown as average values from a 2-day observation (n= 6). c, d Plasma leptin levels of 12-week-old Grasp55+/+ and Grasp55−/− mice
that were fasted for 16 h and fed ND (n= 6). Plasma leptin levels normalized to body fat mass of mice are presented in d (n= 6). e, f Fasting plasma levels
of insulin (e) and glucose (f) were measured in 12-week-old Grasp55+/+ and Grasp55−/− mice fasted for 16 h (n= 6). g An insulin tolerance test was
performed in mice fasted for 4 h. The relative ratios of blood glucose levels to basal glucose levels were determined at the indicated time points following
intraperitoneal administration of human insulin (0.75 U kg−1 body weight) in 12-week-old Grasp55+/+ and Grasp55−/− mice (n= 6). Data are shown as
mean ± SEM. n.s.: not significant, *p < 0.05, **p < 0.01. All p values were calculated by unpaired two-tailed Student’s t tests. Source data are provided as a
Source Data file.
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LD-associated lipases, such as ATGL and MGL, were identified in
the Golgi fraction and their contents in the Golgi were markedly
reduced in the jejunum of Grasp55−/− mice (Fig. 5a; Supple-
mentary Fig. 8). The presence of ATGL (Supplementary Fig. 9)
and MGL (Supplementary Fig. 10) in the Golgi was also
confirmed by immunostaining. Notably, deficiency of GRASP55
diminished colocalization of the LD-associated lipases and the
Golgi marker protein GM130, which was more marked under
lipid-rich conditions (after olive oil feeding; Supplementary Figs. 9,
10). Moreover, the defects in Golgi localization were associated
with reductions in the total amount of ATGL (Fig. 5b, c;
Supplementary Fig. 11a–d) and MGL (Supplementary Fig. 11e, f)
proteins in the Grasp55−/− jejunum. However, mRNA levels of
the genes encoding these proteins were not affected by GRASP55
deficiency (Supplementary Fig. 11g, h).
LDs in enterocytes are believed to be a transient pool of stored
lipids that provide sustained lipid supply for chylomicron
assembly and secretion after a meal19. Because ATGL regulates
LD lipid content25 and its protein amount was more significantly
reduced by GRASP55 deficiency than MGL (Fig. 5b, c;
Supplementary Fig. 11e, f), we further investigated the role of
GRASP55 in the intracellular regulation of ATGL as a model for
the Golgi-traveling LD proteins. Notably, the Golgi localization
defects of ATGL appeared to cause failure of LD targeting, and
thus the amount of ATGL in LD (Fig. 5d, e) and colocalizations
between ATGL and the LD marker protein ADRP (Fig. 5f, g)
were profoundly reduced in the jejunums of Grasp55−/− mice.
The LD-targeting failure of ATGL upon GRASP55 depletion was
also evident in Caco-2 (Fig. 6a–c) and HeLa cells (Supplementary
Fig. 12) using short-hairpin RNAs (shRNAs) against GRASP55
and staining LDs with BODIPY dye. In vitro analyses in Caco-2
cells revealed that GRASP55 depletion resulted in decreased
stability of ATGL (Fig. 6d, e). Of note, these LD localization and
protein stability defects of ATGL caused by GRASP55 depletion
were rescued by supplementation with exogenous GRASP55
(GRASP55-Myc) in Caco-2 (Fig. 6c–e) and HeLa cells (Supple-
mentary Fig. 12). Furthermore, a high level of exogenous ATGL
(ATGL-Myc) supplementation, which restored LD-associated
ATGL levels in GRASP55-depleted cells, rescued the transepithe-
































































+/+ –/– +/+ –/–
























+/+ –/– +/+ –/–






















































Fig. 3 GRASP55 deficiency causes supersized LDs in intestinal epithelium. a–c H&E and Oil Red O staining images of jejunal epithelia. Intestinal tissues
were taken from 12-week-old Grasp55+/+ and Grasp55−/− mice that were fasted for 16 h (a) or 4 h after oral gavage of olive oil (b, 10 μl g−1 of body
weight). Quantification of stained lipid droplets (LDs) was performed by measuring sample absorbances at 510 nm (c, n= 7). The readings were
normalized to the background value obtained from a non-induced fasting control. Scale bars: 50 μm. d Intestinal triglyceride (TG) contents were measured
in jejunums of 12-week-old Grasp55+/+ and Grasp55−/− mice that were fasted for 16 or 4 h after olive oil bolus (olive oil, 10 μl g−1 of body weight, n= 6).
e Electron-microscopic (EM) images of mouse jejunum 4 h after oral gavage of olive oil (10 μl g−1 of body weight). Arrows indicate cytosolic LDs.
Quantitative analyses of LD diameters are summarized in (f) (Grasp55+/+, n= 313 from five mice; Grasp55−/−, n= 307 from five mice). Dashed circle
represents the supersized LD (diameter, >5 μm). GRASP55 deficiency increased the LD size from 0.74 ± 0.02 μm to 3.19 ± 0.16 μm (p < 0.01). Scale bars: 5
μm. g, h EM images showing chylomicrons of mouse intestinal epithelial cells. Mouse jejunums were prepared 2 h after oral gavage of olive oil. Arrows
indicate chylomicron particles. Quantitative analyses of chylomicrons are summarized in (h). The number of chylomicron particles in each EM field (3.72 ×
3.72 μm) of the Golgi region was determined (n= 50 from five mice each). Scale bars: 500 nm (enlarged: 200 nm). Data are shown as mean ± SEM. n.s.:
not significant, **p < 0.01. All p values were calculated by unpaired two-tailed Student’s t tests. Source data are provided as a Source Data file.
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of GRASP55-Myc alone did not significantly affect the LD
targeting and protein stability of ATGL in control cells (Fig. 6c–e;
Supplementary Fig. 12).
Immunoprecipitation assays in Caco-2 cells showed that
GRASP55 reciprocally associated with ATGL, which was further
augmented under lipid-rich conditions that was mostly due to
increased total cellular amounts of ATGL (Fig. 7a–d). However,
GRASP55 did not localize on LDs even under lipid-rich
conditions (Fig. 5a; Supplementary Fig. 13), suggesting that
GRASP55 interacts with ATGL primarily at the Golgi, where both
proteins are enriched (Fig. 5a). Notably, pull-down assays using
protein fragments of GRASP55 and ATGL indicated that the
GRASP55-PDZ1 domain directly interacts with the ATGL-
patatin domain (Fig. 7e, f). The ATGL-patatin domain has been
shown to interact with many other regulatory proteins of ATGL,
such as CGI58, HILPDA, and G0S227. Altogether, the above
results suggest that GRASP55 participates in Golgi localization of
ATGL via physical association.
To gain mechanistic insight into how GRASP55 regulates
ATGL trafficking and stability, we analyzed ATGL levels in the
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Fig. 4 GRASP55 is required for intestinal fat absorption and chylomicron secretion. a An oral fat tolerance test was performed with 12-week-old male
mice after oral gavage of olive oil (10 μl g−1 of body weight). Tyloxapol (Triton WR-1339) was administered 20min after the olive oil gavage (arrow, 0.5 g
kg−1 intravenous injection) to inhibit lipoprotein catabolism. Plasma triglyceride (TG) concentrations were measured at the indicated time points (n= 6).
b Photograph of blood plasma taken from WT and Grasp55−/− male mice 2 h after application of olive oil. c, d Fractionation analysis of plasma lipids from
mice using fast performance liquid chromatography. Blood samples were taken 2 h after oral garage of olive oil. TG concentrations were determined in each
fraction. The area under curve (AUC) of plasma lipoprotein fractions were measured using ImageJ software and summarized in (d, n= 3 independent
experiments from pooled blood plasma samples of 3–4 mice). e Schematic diagram of the in vitro two-chamber system with differentiated Caco-2 cells.
f Immunoblot results showed that the short-hairpin RNA against GRASP55 (shGRASP55) specifically depleted endogenous GRASP55 protein expression and
GRASP55 with a COOH-terminal Myc-tag (GRASP55-Myc) induced exogenous GRASP55 protein. The filled arrowhead and the open arrowhead indicate
levels of exogenous GRASP55 and endogenous GRASP55, respectively. Aldolase A was monitored as a cytosolic protein loading control. g Transepithelial
lipid transport of Caco-2 monolayers were determined using 14C-labeled oleic acid. The majority of the exogenous oleic acids were incorporated into TGs
and secreted as TGs in Caco-2 cells47. Basolateral (B) to apical (A) transport of lipids (left, B to A) was much smaller than that of apical to basolateral
transport (middle, A to B), and was not affected by GRASP55 depletion or overexpression. Specific transepithelial lipid absorption was determined by
subtracting values of (B to A) from those of (A to B) in each paired experiment (right, n= 5). GRASP55 depletion reduced lipid absorption by 49.2 ± 14.5%.
GRASP55 overexpression rescued the lipid absorption defect in GRASP55-depleted Caco-2 cells. CPM, counts per min. CM, chylomicron, VLDL, very-low-
density lipoprotein; IDL, intermediate density lipoprotein; LDL, low density lipoprotein; HDL, high density lipoprotein. Unprocessed blots can be found in
Supplementary Fig. 22. Data are shown as mean ± SEM. n.s.: not significant, *p < 0.05, **p < 0.01. P values were calculated by unpaired (a, c), paired (d)
two-tailed Student’s t tests or ANOVA followed by Tukey’s multiple comparison tests (g). Source data are provided as a Source Data file.
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cytosol and LDs after treatment with the proteasomal inhibitor
MG132. Interestingly, MG132 reversed the decreased cytosolic
levels of ATGL caused by GRASP55 depletion (Fig. 8a, b), which
was consistent with a previous report showing that non-LD-
associated ATGL was sensitive to proteasomal degradation28.
However, MG132 did not significantly affect LD-associated ATGL
levels that had been reduced in GRASP55-depleted cells (Fig. 8c,
d). In contrast, the add-back of GRASP55 restored ATGL levels in
both the cytosol and LDs (Fig. 8a–d). We then analyzed the
association between GRASP55 and ATGL after blockade of ER-to-
Golgi trafficking by dominant-inhibitory forms of SAR1 (SAR1-
T39N) and ARF1 (ARF1-T31N). SAR1 is a GTPase that plays a
critical role in the COPII-mediated conventional ER-to-Golgi
transport29. Although ARF1 is known to play a central role in
COPI-mediated retrograde Golgi-to-ER transport, its inhibition by
dominant-inhibitory ARF1 mutants also blocks anterograde ER-
to-Golgi transport29. Notably, the interaction between GRASP55
and ATGL was abolished by the ER-to-Golgi blockade, suggesting
that transport of ATGL to the Golgi is required for ATGL to
associate with GRASP55 (Fig. 8e, f). As reported earlier28, SAR1
and ARF1 inhibition reduced ATGL levels in the cytosol and LDs
(Supplementary Fig. 14). While MG132 recovered the cytosolic
ATGL levels that were reduced by the ER-to-Golgi blockade
(Supplementary Fig. 14), it did not recover the defects in the
GRASP55-ATGL association (Fig. 8e, f) or the reductions in LD-
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Fig. 5 GRASP55 participates in the Golgi localization and LD targeting of ATGL and MGL. a Subcellular localization of ATGL and MGL in the intestinal
epithelial cells of Grasp55+/+ and Grasp55−/− mice was determined using LD floating ultracentrifugation (for Fraction 1), followed by subcellular
fractionation assay (for Fractions 2–9; using pooled jejunum tissue from four male mice 4 h after olive oil bolus [olive oil, 10 μl g−1 of body weight]) as
described in Methods. RAB18/ADRP, Aldolase A, Giantin, ERGIC53, and calreticulin were used as organelle markers of the LDs, cytosol, Golgi, the ER-Golgi
intermediate compartment (ERGIC), and the ER, respectively. Immunoblotting results with a full list of proteins involved in lipid metabolism are shown in
the Supplementary Fig. 8. The Golgi localizations of ATGL and MGL were reduced by GRASP55 deficiency in mouse intestinal cells (red boxes). Three
independent experiments showed similar results. b, c The protein expressions of ATGL, phospho-HSL (pHSL), HSL, MTP, and ADRP were analyzed by
immunoblotting. Jejunum tissues were prepared from Grasp55+/+ and Grasp55−/− mice fasted for 16 or 4 h after olive oil bolus (olive oil, 10 μl g−1 body
weight). Representative immunoblots are shown in (b). Densitometric analysis of ATGL are shown in (c, n= 5). A summary of pHSL, HSL, MTP, and ADRP
is shown in Supplementary Fig. 11a–d. The level of β-actin was monitored as a cytosolic protein loading control. d, e Measurements of ATGL in the lipid
droplet (LD) fraction of intestinal epithelial cells (using pooled jejunum tissue from four male mice 4 h after olive oil bolus [olive oil, 10 μl g−1 of body
weight]). Representative immunoblots are shown in (d) and a summary of multiple experiments is shown in (e, n= 3). TM, total membrane.
f, g Intracellular localization of ATGL and ADRP, a marker protein of LD, in jejunal epithelia of mice 4 h after olive oil bolus. Representative images are
shown in (f) and quantitative analyses of colocalization between ATGL and ADRP are presented in (g, n= 5). MCC, Manders’ colocalization coefficient.
Unprocessed blots can be found in Supplementary Fig. 22. Data are shown as mean ± SEM. Scale bars: 20 μm. **p < 0.01. P values were calculated by
unpaired (c, g) or paired (e) two-tailed Student’s t tests. Source data are provided as a Source Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14912-x ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:1418 | https://doi.org/10.1038/s41467-020-14912-x | www.nature.com/naturecommunications 7
(Supplementary Fig. 14). In aggregate, these results imply that
defective LD localization of ATGL is the primary event caused by
GRASP55 depletion, and that the restoration of cytosolic ATGL
levels to near control levels is not sufficient to recover the LD
trafficking defect of ATGL.
Cellular localizations (Supplementary Fig. 8) and levels (Fig. 5b;
Supplementary Fig. 11a–d) of other LD-related proteins in the
mouse jejunum, such as HSL, MTP, and ADRP, were not altered.
Recent reports suggested that some Golgi proteins, such as ARF1,
ARFRP1, and GBF1, are involved in the regulation of LD and
chylomicron formation23,30; however, GRASP55 depletion did not
affect their cellular localizations or levels in mice (Supplementary
Fig. 8) and Caco-2 cells (Supplementary Fig. 15). It has been shown
that GRASP proteins are involved in autophagy31,32, which is
known to play a role in LD dynamics in enterocytes33. To analyze
the effects of autophagy, we examined the conversion of
microtubule-associated protein light chain 3 (LC3) into its
phosphatidylethanolamine-conjugated form (LC3-II) as a para-
meter of autophagic flux. As shown in Supplementary Fig. 16,
Grasp55 deletion did not significantly affect autophagic flux in the
mouse jejunum, suggesting that altered autophagy is not responsible






















































































































































































































































































































Fig. 6 GRASP55 depletion reduces LD targeting of ATGL and transepithelial lipid absorption in Caco-2 cells. a, b Measurements of ATGL in the lipid
droplet (LD) fraction of Caco-2 cells after treatment with 400 μM oleic acid for 16 h. Representative immunoblots are shown in (a) and a summary of
multiple experiments is shown in (b, n= 3). c Presence of ATGL on the LD surface was examined by co-staining with anti-ATGL antibodies and BODIPY
493/503 (an LD marker) in Caco-2 cells, in which endogenous GRASP55 was depleted (shGRASP55, shG55) and/or exogenously supplemented (GRASP55-
Myc, G55-Myc). Cells were treated with 400 μM oleic acid for 4 h before immunostaining. Arrows indicate the location of ATGL, which is targeted to the
peripheral regions of LDs. Four independent experiments showed similar results. d, e ATGL protein stability was examined in Caco-2 cells, in which
GRASP55 was depleted (shGRASP55, open arrowhead) and/or exogenously supplemented (GRASP55-Myc, filled arrowhead). Cytosolic proteins were
collected 0, 2, and 4 h after treatment with cycloheximide (0.1 mgml−1), an inhibitor of protein biosynthesis. Aldolase A was used as a cytosolic protein
loading control. Representative immunoblot is shown in (d), and the results of multiple experiments are summarized in (e, n= 3). f Immunoblot results of
Caco-2 monolayers, in which GRASP55 was depleted (shGRASP55) and exogenous ATGL (ATGL-Myc) was supplemented. Levels of endogenous ATGL
(open arrowhead) and exogenous ATGL (filled arrowhead) are shown. A high level of ATGL-Myc supplementation restored LD-associated ATGL levels in
GRASP55-depleted cells, although the LD transport efficiency was much lower (compare endogenous and exogenous ATGL levels in lanes 3 and 4).
g Transepithelial lipid transport of Caco-2 monolayers were determined using 14C-labeled oleic acid. The basolateral (B) to apical (A) transport of oleic acid
(left, B to A) was much smaller than that of apical to basolateral transport (middle, A to B), and it was not affected by GRASP55 depletion or ATGL
overexpression. Transepithelial lipid absorption was determined by subtracting values of (B to A) from those of (A to B) in each paired experiment (right, n
= 4). ATGL overexpression rescued lipid absorption in GRASP55-deficient Caco-2 Cells. Unprocessed blots are presented in Supplementary Fig. 22. CPM,
counts per min. TM, total membrane. Data are shown as mean ± SEM. Scale bars: 10 μm. n.s.: not significant, *p < 0.05. P values were caluculated by paired
(b), unpaired (e) two-tailed Student’s t tests or ANOVA followed by Tukey’s multiple comparison tests (g). Source data are provided as a Source Data file.
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The decrease in ATGL protein levels by GRASP55 deficiency
was also observed in the mouse liver (Supplementary Fig. 17a–d).
As an LD-associated lipase, reduced ATGL levels were expected
to cause an enlarged LD. However, in contrast to those of the
jejunum, LD size (Supplementary Fig. 17e, f) and TG contents
(Supplementary Fig. 17g) of hepatocytes were reduced. Taken
together with those in adipocytes (Fig. 1g–j; Supplementary
Fig. 2), reduced lipid contents in hepatocytes imply that impaired
intestinal fat absorption by GRASP55 deficiency dominantly
affects the organismal level of lipid handling in mice.
Lipid accumulation defects in Grasp55−/− mice are rescued by
the supplementation of GRASP55. Next, we generated mice
overexpressing GRASP55 with a COOH-terminal Myc-tag
(TgGrasp55) and crossed them with Grasp55−/− mice to examine
whether the lipid accumulation defect phenotype of Grasp55−/−
mice is rescued by GRASP55 supplementation. The body size,
weight, and lipid storage of control TgGrasp55 mice on the WT
background were comparable to those of WT mice (Fig. 9a–f).
Immunostaining with the Golgi marker protein GM130 revealed
that transgenic GRASP55-Myc proteins were mostly localized on
the Golgi apparatus in jejunal epithelial cells (Supplementary
Fig. 18). Importantly, transgenic expression of GRASP55 restored
the growth and body weights of Grasp55−/− mice (Fig. 9a, b) and
rescued the organ size and fat contents of adipose tissues
(Fig. 9c–f). Furthermore, transgenic GRASP55 eliminated exces-
sive lipid accumulation in the small intestine after intragastric
olive oil application (Fig. 9g) and restored the reduced levels of
ATGL (Fig. 9h, i) in the Grasp55−/− mouse jejunum. These
results indicate that GRASP55 deficiency is responsible for the
















































































































































































































































































































Fig. 7 GRASP55-PDZ1 interacts with ATGL-patatin. a–d Coimmunoprecipitation experiments with anti-Myc antibodies were performed in Caco-2 cells.
For the induction of ATGL protein expression, some cells were treated with 400 μM oleic acid for 16 h. A representative coimmunoprecipitation assay
using GRASP55 with a COOH-terminal Myc-tag (GRASP55-Myc) is shown in (a), and the results of multiple experiments are summarized in (b, n= 3). A
representative coimmunoprecipitation assay using ATGL with a COOH-terminal Myc-tag (ATGL-Myc) is shown in (c), and the results of multiple
experiments are summarized in (d) (n= 3). Aldolase A was used as a cytosolic protein loading control. e, f Pull-down assays were performed with
GRASP55 and ATGL fragments. The domain structures of His6-tagged GRASP55 and GST-tagged ATGL constructs used in this study are shown in (e), and
a representative result from the pull-down assay is shown in (f). Expression of control GST and each GST-fusion protein is visualized by Ponceau S staining
(f lowermost panel). An asterisk indicates the band of each GST-tagged protein. One microgram of each His6-tagged protein was loaded as an input
control. The PDZ1 domain of GRASP55 interacted strongly with the ATGL-patatin domain. Three independent experiments showed similar results.
Unprocessed blots can be found in Supplementary Fig. 22. Data are shown as mean ± SEM. n.s.: not significant, *p < 0.05, **p < 0.01. All p values were
calculated by paired two-tailed Student’s t tests. Source data are provided as a Source Data file.
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Grasp55−/− mice and that nonspecific or off-target effects are not
involved in the altered lipid metabolism of Grasp55−/− mice.
Lipid storage defects of dGrasp−/− are restored by the
enterocyte-specific supplementation of dGRASP or BMM in
Drosophila melanogaster. To test whether the role of GRASP in
lipid absorption is evolutionarily conserved, we examined the lipid
storage phenotypes of GRASP deletion in fly. We obtained a fly
strain with the dGrasp-null mutant allele (dGrasp−/−), also known
as dGrasp302, harboring the deletion of the entire dGrasp coding
region34. The dGrasp-null flies (dGrasp−/−) are viable, but the
females are sterile. Notably, dGrasp-null flies exhibited lipid accu-
mulation in their posterior midguts after a standard diet feeding
(Fig. 10a–d) and decreased whole-body TG contents (Fig. 10e),
implying defective intestinal lipid absorption (control [1st lane] vs.
dGrasp−/− [2nd lane], Fig. 10d, e). The introduction of dGrasp
cDNA in the dGrasp−/− background using NP1-GAL4, which
specifically labels enterocytes35, restored whole-body fat amounts
and rescued the intestinal lipid accumulation defect (dGrasp−/−
[2nd lane] vs. NP1>dGrasp;dGrasp−/− [4th lane], Fig. 10d, e).
Enterocyte-specific knockdown of dGrasp (NP1>dGrasp-i) also
evoked lipid accumulation in the fly midgut (Supplementary
Fig. 19a, b). Collectively, these results suggest that the lipid hand-
ling defects of dGrasp−/− flies are due to loss of dGrasp in
enterocytes.
Because mutation of Grasp55 in mice caused ATGL mislocaliza-
tion and decreased expression levels in the jejunum, we next sought
to test whether the intestinal lipid accumulation defect of dGrasp−/−
flies can be rescued by overexpression of Drosophila lipid storage
droplet-associated TG lipase Brummer (BMM), a homolog of
mammalian ATGL17. The increased lipid accumulation in the
midgut of dGrasp−/− flies was rescued by overexpression of
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Fig. 8 Decreased ATGL levels in LDs by GRASP55 depletion are not reversed by proteasome inhibition. a–d Immunoblot analysis of ATGL levels in
Caco-2 cells, in which GRASP55 was depleted (shGRASP55) and/or exogenously supplemented (GRASP55-Myc). Cytosolic proteins were collected in the
absence or presence of the proteasomal inhibitor MG132 (0.5 μM, 16 h). For the induction of ATGL protein expression, cells were treated with 400 μM
oleic acid for 16 h. Representative immunoblots of cytosols and LDs are shown in (a) and (c), and the results of multiple experiments are summarized in (b)
and (d), respectively (n= 3 each). Aldolase A and RAB18/ADRP were used as loading controls for cytosolic and LD proteins, respectively. MG132 reversed
the decreased cytosolic levels of ATGL by GRASP55 depletion, but did not significantly affect the ATGL levels in LDs. In contrast, the add-back of GRASP55
restored ATGL levels in both the cytosol and LDs. e, f Coimmunoprecipitation (IP) experiments with anti-GRASP55 antibodies were performed in Caco-2
cells. The ER-to-Golgi trafficking was blocked by dominant-inhibitory forms of SAR1 (SAR1-T39N) and ARF1 (ARF1-T31N). For the induction of ATGL
protein expression, cells were treated with 400 μM oleic acid for 16 h. A representative IP assay is shown in (e), and the results of multiple experiments are
summarized in (f, n= 3). Aldolase A was used as a cytosolic protein loading control. MG132 does not rescue the dissociation of GRASP55 and ATGL
induced by SAR1-T39N and ARF1-T31N. Unprocessed blots can be found in Supplementary Fig. 22. Data are shown as mean ± SEM. **p < 0.01, difference
from control without MG132. ##p < 0.01, difference from control. All p values were calculated by ANOVA followed by Tukey’s multiple comparison tests.
Source data are provided as a Source Data file.
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(dGrasp−/− [2nd lane] vs. NP1>bmm;dGrasp−/− [6th lane],
Fig. 10d). Importantly, the reduced whole-body TG levels were also
restored by the intestinal BMM supplementation (dGrasp−/− [2nd
lane] vs. NP1>bmm;dGrasp−/− [6th lane], Fig. 10e). These results
indicate that reduced TG hydrolysis in LD is responsible for the
GRASP deficiency-induced excessive lipid accumulation and
reduced intestinal lipid absorption in the Drosophila midgut.
Interestingly, deletion of bmm also induced intestinal lipid
accumulation in flies; however, this defect was not reversed by
dGrasp supplementation (Supplementary Fig. 19c, d), indicating that
bmm is epistatic to dGrasp and also most likely located downstream.
Discussion
In the present study, we have shown that the Golgi and GRASP55
functions are critically involved in lipid homeostasis, in
particular, by regulating intestinal lipid uptake. We found that
intestinal chylomicron secretion and LD regulation are sensitive
to Golgi defects evoked by GRASP55 deficiency. Notably, some
LD-associated proteins, such as ATGL and MGL, reach their final
destination via the Golgi complex. Previously, a group of reports
showed that blocking the function of COPI and ARF1 evoke
supersized LDs, presumably through deterioration of ATGL
function (BMM in Drosophila) in mammalian and Drosophila
cells28,36. The authors initially thought that COPI-mediated
transport from the ER or the ER-Golgi intermediate compart-
ment (ERGIC), rather than the Golgi, might be responsible for
the LD targeting of ATGL. However, blocking the function of
COPI and ARF1 also disrupts the Golgi both structurally and
functionally37. Furthermore, results in the present study showed
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Fig. 9 GRASP55 deficiency-induced lipid storage defects are rescued by supplementation of GRASP55 in mice. Wild-type (Grasp55+/+) and
Grasp55−/− mice were crossed with transgenic mice overexpressing GRASP55-Myc (TgGrasp55). a, b Photographs (a) and a summary of body weight
(b, n= 6) of 12-week-old male mice. c, d Photographs (c) and a summary of weight (d, n= 6) of epididymal white adipose tissues (EWAT, right side).
e, f Representative light microscopic images (H&E) of EWAT are shown in (e). Quantitative analyses of the H&E images, that inversely correlate with fat
contents of EWAT by counting the number of adipocyte nuclei in a light microscopic field (450 × 340 μm), are presented in (f, n= 6). g H&E and Oil Red O
staining of mouse jejunum 4 h after olive oil bolus (10 μl g−1 body weight). TgGrasp55(+) reduced the postprandial lipid accumulation of jejunal epithelia in
Grasp55−/− mice. Arrows indicate supersized LDs. h, i The protein amount ATGL of mouse jejunum was analyzed by immunoblotting. Representative
immunoblots are shown in (h). In some experiments, jejunum tissues were prepared 4 h after olive oil bolus (10 μl g−1 body weight). The filled arrowhead
and open arrowhead indicate levels of the exogenous GRASP55-Myc and endogenous GRASP55, respectively. A blot with a longer exposure time of
GRASP55 is shown in the left four lanes to better visualize the presence and absence of endogenous GRASP55. The results of multiple experiments (n= 4)
are summarized in (i). TgGrasp55(+) increases the protein levels of ATGL in jejunal epithelia of Grasp55−/− mice. Unprocessed blots can be found in
Supplementary Fig. 22. Data are shown as mean ± SEM. Scale bars: 50 μm. n.s.: not significant, **p < 0.01. P values were calculated by unpaired two-tailed
Student’s t tests (b) or ANOVA followed by Tukey’s multiple comparison tests (d, f, i). Source data are provided as a Source Data file.
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Supplementary Fig. 8) and deficiency of the Golgi protein
GRASP55 markedly reduces the amount of ATGL in the Golgi
and LD (Fig. 5a, d, e; Supplementary Fig. 9), implying that
blocked ATGL transport from the Golgi could be primarily
responsible for the supersized LDs induced by COPI and ARFI
inhibition28,36. Therefore, increased LD size by COPI and ARF1
inhibition28,36 are compatible with the present findings of
GRASP55 deficiency in the mouse jejunum (Fig. 3). However, in
other tissues, such as fat tissues (Fig. 1g–j) and liver
(Supplementary Fig. 17), the same GRASP55 deficiency caused
collapse of LDs, suggesting that retarded intestinal fat absorption
is the dominant phenotype of global deletion of the Grasp55 gene
in vivo, and thus maintaining the Golgi-mediated chylomicron
secretion would be one of the most important physiological roles
of GRASP55 in live animals.
Recent evidence suggests that some Golgi proteins are involved
in the lipidation of the cytosolic organelle LD. For example, two
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Fig. 10 The role of dGRASP in intestinal lipid absorption and whole-body TG storage in adult flies. The dGrasp-null mutant allele (dGrasp−/−), also
known as dGrasp302, harbors a deletion of the whole dGrasp coding region. a, b Lipid accumulation in enterocytes of posterior midguts of dGrasp−/− flies.
Enterocytes of NP1>mCD8::RFP fly guts were stained with antibodies against DsRed (green) and nuclei were counterstained with TO-PRO-3 (blue). Lipids
were visualized by staining with BODIPY solution (red). For consistency, pseudocolors were used. Confocal microscopic images of whole guts from control
(NP1>mCD8::RFP) and dGrasp-mutant flies (NP1>mCD8::RFP;dGrasp−/−) are shown in (a). Scale bars: 1 mm. Boxed area indicates the posterior midgut
where lipids accumulated. Image sections of the boxed area taken from the top (upper, scale bar: 25 μm) and lateral (bottom, scale bar: 10 μm) orientations
are shown in (b). c, d Confocal microscopic images of lipid accumulation in the fly guts of the indicated genotypes. The fly genes dGrasp and bmm are
homologs of mammalian GRASP and ATGL, respectively. Each gene was expressed in the enterocytes of dGrasp−/− flies under the control of NP1-GAL4.
Lipids were visualized by staining with Nile Red (red) and nuclei were counterstained with TO-PRO-3 (blue). Representative images of the posterior
midguts are shown in (c), and quantitative analyses of intestinal lipid accumulation in the indicated genotypes of the flies are presented in (d), n= 4–6.
Scale bars: 50 μm. e Quantitative analyses of relative whole-body TG contents in the indicated genotypes of the flies (n= 5). UAS, upstream activation
sequence. Data are shown as mean ± SEM. *p < 0.05, **p < 0.01. All p values were calculated by ANOVA followed by Tukey’s multiple comparison tests.
Source data are provided as a Source Data file.
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on the trans-Golgi, Golgins and RAB proteins, have been shown
to participate in the control of LD morphology and trafficking38.
Based on this finding that the ARFRP1-ARL1-Golgin-RAB cas-
cade is involved in LD lipidation, it has been proposed that LDs
may travel through the Golgi39. While chylomicrons travel
through the Golgi lumen, LDs, if they do indeed travel through
the Golgi, may do so via peripheral association because they are
present in the cytosolic space. However, in our extensive EM
examinations, we were unable to find any Golgi structures that
were peripherally associated with LD-like structures. Although it
is uncertain whether LDs themselves can physically interact with
and travel through the Golgi, the present results indicate that at
least some LD proteins travel through the Golgi before targeting
LDs. Interestingly, blockade of ER-to-Golgi transport by SAR1
and ARF1 inhibition reduced LD localization of RAB18 and
ADRP as well as that of ATGL (Supplementary Fig. 14). In
contrast, GRASP55 depletion inhibited LD localization of ATGL
without affecting that of RAB18 and ADRP (Supplementary
Fig. 14), indicating that ATGL is individually recruited to the LD
by GRASP55 after traveling through the Golgi. The IP results, in
which interactions between GRASP55 and ATGL were prevented
by the blockade of ER-to-Golgi transport (Fig. 8e, f), further
demonstrate that ATGL associates with GRASP55 at the Golgi.
The GRASP55 deletion evoked an increase in the luminal width
of some Golgi stacks (Supplementary Fig. 6). Although we cannot
completely rule out the possibility that Golgi flatness defects
contributed to reduced chylomicron secretion, such contribution
appeared to be minimal because only 7.5% of the Golgi stacks
showed an abnormal enlargement (>0.1 μm).
The gene supplementation and depletion experiments invol-
ving bmm in Drosophila provide mechanistic insights into how
GRASP deficiency can induce the defects in intestinal lipid
transport (Fig. 10), indicating that mobilization of lipids from
LD-associated TGs is required for efficient transepithelial fat
absorption. Epithelial cells in the Drosophila gut secrete dia-
cylglycerol (DAG) into hemolymph (Drosophila circulation) as a
major source of lipids with the help of APOB lipoproteins LPP
and LTP40,41, while mammalian enterocytes principally secrete
TGs into the blood in the form of APOB-containing chylomi-
crons. Therefore, inhibition of the conversion of TGs to DAG by
BMM depletion may directly inhibit DAG secretion into hemo-
lymph, and thus inhibit dietary lipid absorption in Drosophila.
However, the mechanism of cytosolic LD-associated TG mobili-
zation for chylomicron secretion in mouse enterocytes appears to
be more complex.
Intestinal deficiency of the ATGL cofactor CGI58 reduces
postprandial lipid absorption in mice, suggesting that mobilization
of LD-associated TG is also required for lipoprotein-mediated
lipid secretion in mammals42. Interestingly, in contrast to CGI58
deficiency, intestinal ATGL deficiency did not noticeably inhibit
lipid absorption in mice43. The reasons for the discrepancy
between CGI58 and ATGL deficiencies are unclear at present. A
plausible scenario is that CGI58 activates lipase(s) other than
ATGL, which would constitute the salvage pathway for mobili-
zation of LD-associated TGs; and therefore, CGI58 deficiency can
inhibit intestinal fat absorption while deficiency of ATGL alone
does not. Notably, deficiency of MGL, which also exhibited
reduced Golgi localization and cellular expression in response to
GRASP55 deficiency in the present study (Fig. 5a; Supplementary
Figs. 8, 10, 11), has been shown to inhibit lipid absorption44.
Therefore, combinatorial effects caused by mislocalization of
multiple Golgi-traveling LD proteins, including ATGL and MGL,
appear to be responsible for the GRASP55 deficiency-induced
reductions in intestinal lipid uptake in mice. A further dissection
of TG mobilization from LDs to chylomicrons, including the
potential role of MGL in this pathway, may contribute to the
search for effective therapeutic target molecules against obesity-
associated diseases.
A recent study reported that deletion of dGrasp in flies reduced
body TG contents, similar to the results of the present study18.
However, in that study, the fat storage defect of GRASP-deleted
flies could be rescued by fat body-specific dGrasp supplementa-
tion18, in contrast to the present observation that the fat storage
defect of dGrasp-deleted flies was rescued by enterocyte-specific
dGrasp supplementation (Fig. 10e). At present, the reason for the
discrepancies between the two studies is unclear. A potential
mechanism could be an age-dependent effect; Rajan et al. found
that the dGrasp deletion effect on fat bodies was more profound
with age18. They also suggested that Upd2 (Drosophila homolog
of mammalian leptin) is secreted by a dGRASP-mediated
unconventional secretion pathway in Drosophila, and thus dele-
tion of dGrasp resulted in a reduction in Upd2 secretion in adi-
pocytes18. Of note, mammalian leptin possesses a signal peptide
(also known as leader sequence) that brings the cargo protein to
the ER and subsequent Golgi trafficking. This contrasts with
Drosophila Upd2 that does not have a signal peptide (Supple-
mentary Fig. 20). Furthermore, mammalian leptin has two pre-
dicted disulfide bonds while Upd2 does not18, suggesting that the
ER-Golgi luminal environment is important for proper folding of
mammalian leptin, which would be critical for its extracellular
adipokine function. Therefore, it appears that leptin has evolved
to acquire the conventional secretory route in mammalian
organisms that require more sophisticated regulation of energy
metabolism. In the present study, plasma leptin levels were pro-
portional to the body fat mass and the leptin levels normalized to
fat mass were not significantly reduced by GRASP55 deficiency
(Fig. 2d). These results imply that reductions in body fat mass
would be responsible for the decrease in the plasma leptin levels
observed in Grasp55−/− mice (Fig. 2c), and that the unconven-
tional secretory function of GRASP55 does not mediate leptin
secretion in mice. Similarly, reductions in body fat mass appear to
be responsible for the increased insulin sensitivity of Grasp55−/−
mice (Fig. 2g) and the resultant decrease in plasma insulin levels
(Fig. 2e), without affecting plasma glucose levels (Fig. 2f). A
sustained reduction in plasma insulin levels may also contribute
to the growth retardation, and particularly the reduced lean body
masses, observed in Grasp55−/− mice (Supplementary Table 2),
although nutritional imbalance caused by reduced fat absorption
is primarily responsible for the growth retardation.
In conclusion, we used an integrated in vivo and in vitro
approach to demonstrate that GRASP55 plays a key physiological
role in intestinal lipid uptake (Supplementary Fig. 21). GRASP55
deficiency leads to defects in LD targeting of ATGL and MGL,
which causes the formation of supersized LDs and decreased
chylomicron secretion due to reduction in lipid mobilization of
LDs. In addition, low protein levels of ATGL and MGL, due to
increased degradation of the mistargeted proteins, would further
aggravate lipid mobilization of LDs. Increasing evidence suggests
that postprandial serum levels of TGs, chylomicrons, and APOB-
containing chylomicron remnants are important risk factors for
atherosclerosis and metabolic disorders22,45. Therefore, the find-
ing that Grasp55−/− mice displayed reduced fat absorption and
resistance to high-fat diet-induced obesity has enormous impli-
cation in the search for druggable targets against obesity-
associated diseases as well as in elucidating the underpinnings
of digestive physiology.
Methods
Generation of Grasp55−/− and TgGrasp55 mice. For generation of Grasp55−/−
mice, embryonic stem cells harboring the Grasp55 mutation (allele name: Gor-
asp2tm1(KOMP)Vlcg, strain: C57BL/6NTac, coat color: black, purchased from KOMP
Repository, Oakland, CA, USA) were cultured and used in blastocyst injection into
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albino mice for production of chimeric mice (Macrogen Inc., Seoul, Korea). Ani-
mals with a high degree of coat color chimerism were back-crossed to C57BL/6N
mice (Orient Bio Inc., Seoul, Korea) for more than six generations. Germ line
transmission was observed by coat pigment and confirmed by SNP genotyping.
Heterozygous Grasp55+/− mice were used to generate homozygous Grasp55−/−
mice. Primers for genotyping are as follows: GRASP55_WT (endogenous) forward:
5′-TCT CTG AGA GTG TGC TTG CTT AC-3′, reverse: 5′-GGA TTT AGG AGT
TTG GTT AGC TGA-3′, GRASP55_KO (neo cassette) forward: 5′-TCA TTC TCA
GTA TTG TTT TGC C-3′, reverse: 5′-TCC AAA GAT GAA CCT CCC AG-3′.
For the generation of pCAG-GRASP55-Myc transgenic mice, a pRP expression
vector encoding hGRASP55-Myc under the control of cytomegalovirus (CMV)
enhancer fused to the chicken beta-actin promoter (CAG promoter) was obtained
from VectorBuilder (www.vectorbuilder.com). The capability of this construct to
allow GRASP55 expression was tested by transient transfection into HEK293 cells.
The plasmid was digested with ApaLI and SspI to excise a 4-kb fragment and then
microinjected into the pronucleus of fertilized eggs. Injected eggs were implanted
into C57BL/6N surrogate mothers to obtain offspring and genotyping was
performed from pups by PCR to identify those carrying the GRASP55-Myc
transgene (Macrogen Inc.). Protein expression of exogenous GRASP55-Myc was
approximately eight times higher than that of endogenous GRASP55 in the mouse
jejunum (Fig. 9h). Primers for genotyping are as follows: GRASP55 forward: 5′-
TCA CTC ACT GTG GAT GTG ACG-3′, reverse: 5′-GGT TAC AAA TAA AGC
AAT AGC ATC AC-3′.
Mice were bred and maintained according to the Yonsei Medical Center Animal
Research Requirements, and all procedures were approved by the Committee on
Animal Research at Yonsei Medical Center (protocol number 2016-0106). All
animal experiments were performed using male mice and their corresponding
control littermates. Mice had free access to diet and water under a 12-h light/12-h
dark cycle in a temperature-controlled environment. The standard chow diet
contained 10 kcal% of fat (D12450B, Research Diets, New Brunswick, NJ, USA)
and the high-fat diet contained 60 kcal% of fat (D12492, Research Diets).
Cell culture, Caco-2 differentiation, LD staining, plasmids, transfection, and
gene-silencing. HEK293T cells and HeLa cells (American Type Culture Collection
[ATCC], Manassas, VA, USA; tested regularly for mycoplasma) were cultured in a
DMEM medium (Thermo Fisher, Waltham, MA, USA) supplemented with 10%
fetal bovine serum (FBS) and penicillin (50 IUml−1)/streptomycin (50 μg ml−1, all
from Thermo Fisher). Caco-2 cells (ATCC; tested regularly for mycoplasma) were
cultured in a DMEM medium (Thermo Fisher) supplemented with 20% FBS,
penicillin (50 IUml−1)/streptomycin (50 μg ml−1), 2 mM L-glutamine, and non-
essential amino acids (all from Thermo Fisher). For differentiation, Caco-2 cells
were maintained for 3 weeks in a transwell system with a medium change every
2 days. Tight junction formation was verified by measuring transepithelial electrical
resistance. For LD staining, 400 μM oleic acid:bovine serum albumin (BSA)
complex (final concentration ratio 4:1 mM; Merck-Millipore, Burlington, MA,
USA) was applied in the apical chamber for 16 h before harvest. Plasmids encoding
human GRASP55-Myc, HA-Arf1, and Myc-Sar1 were described previously46.
cDNA of GRASP55-Myc was subcloned into pCMV-Myc plasmid. Mutant plas-
mids were generated with a PCR-based site-directed mutagenesis kit (Stratagene,
La Jolla, CA, USA) according to the manufacturer’s protocol. To generate stable
GRASP55 knockdown, GRASP55 overexpression, and ATGL overexpression cell
lines, Caco-2 and HeLa cells were transduced with lentiviral particles produced
from HEK293T cells that had been transfected with the psPAX2 packing plasmid,
pMD2.G envelope plasmid, and pLKO.1 short-hairpin RNA (shRNA) plasmid
(control shRNA: #SHC001, GRASP55-specific shRNA: #TRCN0000129489; Yonsei
Genome Center, Seoul, Korea) or Lenti ORF clone (GRASP55: #RC202946L3,
ATGL: #RC205708L3; Origene, Rockville, MD, USA). Cells stably expressing the
shRNA or indicated genes were selected using puromycin.
Immunoblot and immunoprecipitation assays. Antibodies used in this study are
listed in Supplementary Table 5. For immunoblotting, cells were homogenized in
lysis buffer containing 50 mM Tris pH 7.4, 1% (v/v) NP40, 150 mM NaCl, 1 mM
EDTA supplemented with protease inhibitor mixture (Roche, Applied Science,
Mannheim, Germany). For tissues, the lysis buffer contained additional 100 mM
benzamidine and 0.3% soybean trypsin I. Protein samples were separated by SDS-
polyacrylamide gel electrophoresis. The separated proteins were transferred to a
nitrocellulose membrane at 250 mA of constant current for 1 h 40 min and blotted
with appropriate primary and secondary antibodies. For immunoblotting of plasma
APOB, 2 μl of plasma samples were separated, and transferred at 30 mA of constant
current for 16 h. Protein bands were detected by enhanced chemiluminescence
(ECL) and the densities of the bands were measured using imaging software
(ImageJ, National Institutes of Health, USA, https://imagej.net/Welcome). For
immunoprecipitation, cell lysates were mixed with anti-Myc (Sepharose Bead
Conjugate, Cell Signaling), anti-GRASP55, or control IgG (Merck-Millipore)
antibodies and incubated overnight at 4 °C in a lysis buffer containing 20 mM Tris-
HCl (pH 7.9), 150 mM NaCl, 1% (v/v) Triton X-100, 5 mM Na2EGTA, 5% glycerol,
and the complete protease inhibitor mixture (Roche Applied Science, Mannheim,
Germany). Immune complexes were centrifuged at 4 °C and then washed four
times with lysis buffer before elution with 2× sodium dodecyl sulfate (SDS) sample
buffer and immunoblotted. MG132 and oleic acids were purchased from Merck-
Millipore.
Lipid droplet isolation and subcellular fractionation. The intestinal epithelia of
four male mice 4 h after oral gavage of oil bolus (olive oil, 10 μl g−1 body weight,
Merck-Millipore) were homogenized with a Dounce homogenizer (Merck-Milli-
pore). The postnuclear supernatant (PNS) was collected after centrifugation of the
homogenates at 3000 × g for 10 min and was transferred into a centrifugation tube
for the SW41 rotor (Beckman Coulter, Brea, CA, USA). Washing buffer (2 ml) was
loaded on top of the PNS. The top LD fractions were separated by centrifugation
using an Optima TLX ultracentrifuge (Beckman Coulter) with an SW41 swinging
bucket rotor at 182,000 × g for 1 h. For simultaneous analyses of proteins in LDs
and other organelles (Fig. 5a), remaining fractions were subjected to subcellular
fractionation assays as described below.
Subcellular fractionation using OptiPrep Density Gradient Medium (Merck-
Millipore) was performed as follows. Mouse jejunum tissue was washed with PBS,
chopped into tiny pieces in cell suspension medium containing 0.85% (w/v) NaCl
and 10 mM tricine-NaOH (pH 7.4), and homogenized by repeated passage through
a 30-G syringe needle. PNS was collected after centrifugation of the homogenates at
1500 × g for 10 min and were loaded on top of the density gradient solution
containing 2.5–30.0% (w/v) OptiPrep in cell suspension medium. Subcellular
organelles were separated by centrifugation using an Optima TLX ultracentrifuge
(Beckman Coulter) with a SW41 swinging bucket rotor at 200,000 × g for 2.5 h.
Nine fractions were collected from the top to the bottom, and a 40-μl aliquot of
each fraction was used for immunoblotting.
Immunocytochemical, immunohistochemical, and microscope imaging ana-
lyses. For antibodies see Supplementary Table 5. For immunocytochemical
staining, cells were cultured on 18-mm round coverslips and fixed with 10% for-
malin for 10 min at room temperature. The fixed cells were washed three times
with PBS and then were permeabilized with PBS containing 0.1% Triton X-100
(PBST) for 15 min at room temperature. Cells were incubated with blocking
solution containing 5% donkey serum, 1% BSA, and 0.1% gelatin in PBS for 30 min
at room temperature. After blocking, cells were stained by incubating with the
appropriate primary antibodies overnight at 4 °C. After being washed three times
with PBS, cells were then treated with fluorophore-dye conjugated secondary
antibodies. For LD staining, cells were also stained with BODIPY 493/503 (Merck-
Millipore). Fluorescence images were captured using a laser scanning confocal
microscope with a ×63 1.4 numerical aperture (NA) oil objective lens (LSM 780,
Carl Zeiss, Berlin, Germany).
For immunohistochemical analysis of intestinal tissues, jejunum was isolated,
fixed in 10% neutral-buffered formalin (Merck-Millipore), and embedded in a
paraffin block. Paraffin sections of the jejunum were cut, and antigen retrieval was
performed by heat treatment. Nonspecific binding sites were blocked with 5%
donkey serum, 1% BSA, and 0.1% gelatin in PBS for 30 min. The indicated primary
antibodies were applied overnight at 4 °C. Tissues were treated with fluorophore-
dye conjugated secondary antibodies. Fluorescence images were captured using a
laser scanning confocal microscope with a ×40 1.4 NA water objective lens (LSM
780, Carl Zeiss). To stain the lipid components, paraffin slide of the jejunum was
stained with Oil Red O and Mayer’s hematoxylin. Microscopic images were taken
using an upright microscope BX53 equipped with a Digital Camera DP73 unit
(Olympus Co., Shinjuku, Tokyo, Japan).
Pull-down assay. The antibodies used in this study are listed in Supplementary
Table 5. All recombinant fusion proteins were produced in the BL-21 (DE3)
Escherichia coli strain. The synthesis of GST-fusion and His6-fusion proteins was
induced by the addition of 0.5 mM isopropyl β-D-1-thiogalactopyranoside at 37 °C.
Recombinant proteins were subsequently purified with glutathione Sepharose
beads (GE Healthcare Bio-Science AB, Björkgatan, Uppsala, Sweden) or with a
nickel-nitrilotriacetic acid (Ni-NTA) protein purification system (QIAGEN, Hil-
den, Germany) according to the manufacturer’s instructions. Eluted His6-fusion
proteins were mixed with 20 μg of GST-fusion recombinant proteins bound to
glutathione Sepharose. Following overnight incubation at 4 °C, bead-bound com-
plexes were washed, eluted in SDS sample buffer, and immunoblotted.
Transmission electron microscopy. Jejunum and liver dissected from mice were
immediately fixed for 12 h with 2% glutaraldehyde–paraformaldehyde in 0.1 M
phosphate (pH 7.4) at 4 °C. Samples were rinsed in 0.1 M phosphate buffer, post-
fixed with 1% OsO4, dehydrated in ascending concentrations of ethanol and
propylene oxide, and embedded into Poly/Bed 812 kit (Polysciences, Warrington,
PA, USA). After pure fresh resin embedding and polymerization at 65 °C, samples
were placed in the electron-microscope oven (TD-700, DOSAKA, Japan) for 24 h.
Initially, thick sections of 200–250 nm were cut and stained with toluidine blue
(Merck-Millipore) for light microscopy. Ultrathin sections (~70 nm) were obtained
with an ultramicrotome (UltraCut-UCT, Leica, Austria), which were then collected
on 100-mesh copper grids. After staining with 2% uranyl acetate (15 min) and lead
citrate (5 min), the thin sections were examined by transmission electron micro-
copy at 120 kV (Tecnai G2 Spirit Twin, Thermo Fisher). Diameter of LD and the
Golgi cisternae were analyzed using ImageJ software package as reported
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previously21. The summarized results of LD diameter (Fig. 3f) and maximum
luminal width of Golgi cisternae (Supplementary Fig. 6b) are presented using
frequency distribution histograms.
Mouse plasma parameter assays. WT and Grasp55−/− mice were fasted for 16 h
and blood was collected by cardiac puncture. Blood samples were centrifuged at
1000 × g for 10 min at 4 °C. After centrifugation, 10 μl of the top yellow plasma
layer was transferred into Dry Slide Reagents (Fujifilm Co., Akasaka, Minato,
Tokyo, Japan). Several plasma parameters including triglycerides, total cholesterol,
albumin, total bilirubin, and total protein (Supplementary Table 3) were measured
by using an automated clinical chemistry analyzer, Fuji Dri-chem Nx500 (Fujifilm
Co.) according to the manufacturer’s instructions. Before each measurement, a QC
card (Fujifilm Co.) was used to adjust the lot variability in each of the slide
reagents.
Lipoprotein analysis by fast performance liquid chromatography (FPLC). The
blood from four male mice of each group was collected by cardiac puncture 2 h
after oral oil application. A sample (250 µl) of pooled plasma was subjected to gel
filtration with FPLC for lipoprotein profile analyses. GE Healthcare ÄKTAexplorer
equipped with a Superose 6 10/300 GL column (GE Healthcare Bio-Science AB,
Björkgatan, Uppsala, Sweden) was employed with 10 mM sodium phosphate, 0.15
M sodium chloride, 0.01% (w/v) sodium EDTA, and 0.02% (w/v) sodium azide, pH
7.2 at room temperature. The FPLC system was run with a constant flow of 500 μl
min−1, and fractionation was collected after 5 min with 400 μl per fraction. The
concentrations of triglyceride and total cholesterol in fractions 1–30 were deter-
mined according to the manufacturer’s instruction using Infinity Triglycerides
Reagent or Cholesterol Reagent from Thermo Fisher Scientific Inc. (Middletown,
VA, USA).
Mouse in vivo studies. Metabolic assay: Fat and lean body mass were assessed
using an 1H TD-NMR minispec system (LF90 II, Bruker Optik, Ettlingen, Ger-
many) before and after 4 weeks on HFD. Energy balance, including food con-
sumption and energy expenditure, was evaluated using a metabolic monitoring
system (CLAMS; Columbus Instruments, Columbus, USA) for 4 days (2 days of
acclimation followed by 2 days of measurement) before and after 4 weeks on HFD.
Leptin and insulin assay: To measure plasma leptin levels, mice were fasted for
16 h or allowed free access to food. Blood samples were collected via cardiac
puncture, and leptin concentrations were determined using an immunoassay kit
(Cayman Chemical Company, Ann Arbor, MI, USA). For the insulin tolerance test,
mice were fasted for 4 h. Then, blood samples of 12-week-old male mice were
collected via the tail vein prior to (basal, time 0) as well as after intraperitoneal
injection of insulin (0.75 U kg−1 body weight, Merck-Millipore) at 15, 30, 60, 90,
and 120 min. Plasma glucose concentrations were measured with a glucometer
(Accu-Chek, Roche Diagnostics Corp., IN, USA).
Oral fat tolerance test: For the oral fat tolerance test, mice were fasted for 16 h
and then given 10 μl g−1 of body weight olive oil by oral gavage. In some
experiments, Triton WR-1339 (15% in saline, 0.5 g kg−1; Merck-Millipore) was
injected intravenously into the lateral tail vein 20 min after the olive oil gavage to
inhibit lipoprotein catabolism (Fig. 4a). Blood samples (30 μl) were collected via tail
veins prior to (basal, time 0) as well as 1, 2, 3, and 4 h after oral oil administration.
Blood samples were then centrifuged at 1000 × g for 10 min at 4 °C. After
centrifugation, triglycerides and total cholesterol concentrations of plasma
samples were measured using a colorimetric TG assay kit (Cayman Chemical
Company) and a cholesterol quantitation assay kit (Abcam, Cambridge, UK),
respectively.
Amino acid absorption: WT and Grasp55−/− mice were fasted for 16 h and
then given 10 μl/g of body weight solution containing amino acids dissolved in PBS
(pH 7.4) at a final concentration 10-fold higher than the plasma concentration in
WT animals by oral gavage. The solution was supplemented with 1.5 μCi ml−1 14C-
radiolabeled glycine, L-proline, or L-tryptophan (Moravek, California, CA, USA).
After 1 h, animals were sacrificed, blood was collected by cardiac puncture, and the
amount of radioactivity was determined.
Mouse intestinal lipid assay: To measure intestinal triglyceride and cholesterol
levels, jejunum from WT and Grasp55−/− mice were collected. Lipids were
extracted by the Folch extraction method43. The lipid extract was dried under a
stream of nitrogen, and 1% Triton X-100 in chloroform was added. Lipids were
dried again under a stream of nitrogen gas, and the samples were dissolved in 100
μl H2O. Triglycerides, total cholesterol and cholesteryl ester concentrations were
measured using a colorimetric triglyceride assay kit (Cayman) and a cholesterol
quantitation assay kit (Abcam).
In vitro lipid uptake assay: [1-14C]-radiolabeled oleic acid (55 mCi mmol−1)
and non-labeled oleic acid were purchased from Moravek and Merck-Millipore,
respectively. Radiolabeled and non-labeled oleic acids were conjugated to BSA
(Merck-Millipore) in serum-free DMEM, by addition of concentrated fatty acid in
ethanolic stock such that the amount of ethanol was <0.5% (v/v). The molar ratio
of radiolabeled oleic acid, non-labeled oleic acid, and BSA was 4 μM:4 mM:1 mM.
Media was incubated for 1 h at 37 °C before addition to Caco-2 cells. Differentiated
Caco-2 cell monolayers were washed twice with serum-free DMEM before adding
1 ml fatty acid-BSA complexes to the apical cell surface or 2 ml to the basolateral
side. In the opposite chamber, serum-free DMEM without BSA or fatty acid was
applied. After incubation for 24 h at 37 °C, apical and basolateral media were
collected and centrifuged at 1000 × g for 5 min to remove cell debris. The
radioactivity in the media was analyzed by using Tri-Carb 2910TR Liquid
Scintillation Analyzer (Perkin Elmer, Waltham, MA, USA) and was normalized to
background radioactivity.
Quantitative real-time PCR (qRT-PCR): The intestinal epithelia of male mice
fasted for 16 h were transferred to RNase-free round-bottomed tube and lysed by
using lysis buffer (Thermo Fisher) with 2-mercaptoethanol. After centrifugation at
12,000 × g for 2 min at room temperature, the supernatant was transferred to a
clean RNase-free tube and homogenized by passing 10 times through a 21-G needle
attached to an RNase-free syringe. The supernatant was transferred to a new
RNase-free tube after centrifugation at 12,000 × g for 2 min at room temperature.
RNAs were purified from the lysates using the PureLink RNA Mini Kit (Thermo
Fisher). Purified RNA samples were reverse-transcribed using RNA to cDNA
EcoDry Premixes (Takara Bio Inc., Kyoto, Japan). The total reaction volume was
adjusted to 20 μl with RNase-free water after mixing with 100 ng cDNA, primer
sets, SYBR Premix Ex Taq (Takara Bio Inc.), and ROX reference dye (Takara Bio
Inc.). Amplification was performed with StepOne Plus (Applied Biosystems,
Waltham, MA, USA) under the following cycling conditions: 95 °C for 30 s,
followed by 40 cycles of 95 °C for 5 s, and 60 °C for 30 s. Analyses were performed
in five independent experiments for each cDNA. The relative mRNA expression
levels were calculated using the comparative threshold cycle (Ct) method with
GAPDH as a control, as follows: ΔCt= Ct (GAPDH)− Ct (target gene). The fold-
change in gene expression normalized to GAPDH and relative to the control
sample was calculated as 2−ΔΔCt. Primers for qRT-PCR are as follows: ATGL
forward: 5′-ACC AGC ATC CAG TTC AAC CT-3′, reverse: 5′-ATC CCT GCT
TGC ACA TCT CT-3′, MGL forward: 5′-GGT CAA TGC AGA CGG ACA GT-3′,
reverse: 5′-ATG GAG TGG CCC AGG AGG AA-3′, GAPDH forward: 5′-CAT
CAC TGC CAC CCA GAA GAC TG-3′, reverse: 5′-ATG CCA GTG AGC TTC
CCG TTC AG-3′.
Fly studies. Fly stocks: Flies were maintained on instant fly food purchased from
Carolina (Burlington, NC, #173200) at 25 °C and 60% humidity with a 12 h/12 h
light/dark cycle. Mutant fly strains bmm1 and UAS-bmm:EGFP were provided by
Dr. Ronald P. Kühnlein17. NP1-GAL4 (also known as Myo1A-GAL4,
DGRC112001) was obtained from the Kyoto Stock Center. The dGrasp302
(BL65258), UAS-dGrasp-GFP (BL8507), UAS-mCD8::mRFP (BL27398), and UAS-
dGrasp-RNAi (BL34082) strains were obtained from the Bloomington Stock
Center. All the mutant lines and transgenic lines were back-crossed for five gen-
erations to the w1118 control genotype. For clarity, the w1118 line is referred to as
control throughout the manuscript.
Fly intestine staining: Flies used for dissection were 7- to 14-day-old females.
The guts, from foregut to rectum/anus, were dissected from the flies in 1× PBS.
Isolated guts were fixed with 4% paraformaldehyde in 0.1% Triton X-100 PBS
(PBST) for 30 min, and washed three times in 1× PBS for 15 min each. Fixed
samples were incubated for 30 min with Nile Red solution (N3013, Sigma-
Aldrich, 1 mg ml−1 in acetone) for lipid staining, and TO-PRO-3 solution
(T3605, Invitrogen, 1 mMml−1 in DMSO) for nuclear staining, each at a
dilution of 1:1000 in 0.1% PBST. The samples were washed three times in 1×
PBS for 15 min each and then mounted on a glass slide with Vectashield
mounting medium (H-1000 Vector Laboratories). For enterocyte labeling in
NP1>mCD8::RFP flies, fixed guts were incubated with blocking solution
containing 5% normal goat serum in 0.1% PBST. Next, the samples were
incubated with rabbit DsRed antibodies (1:200, 632496, Clontech) in PBST
overnight at 4 °C, and then with Alexa 568 anti-rabbit (1:400, A11011,
Molecular Probes) for 1 h at room temperature after three washes with
PBST. For lipid staining in these flies, the samples were incubated with
BODIPY solution (D3922, Thermo Fisher Scientific, 1 mg ml−1) at a dilution of
1:1000 in 0.1% PBST for 30 min, and washed twice with PBST. Stained guts were
mounted and visualized using a LSM 700 Zeiss confocal microscope (Jena,
Germany).
TG measurement: The Triglyceride Colorimetric Assay kit (10010303, Cayman
Chemical) and BCA Protein Assay kit (23227, Thermo Fisher Scientific) were used
for measuring triglyceride levels and quantifying proteins, respectively. The heads
of five female flies were removed, and the rest of the bodies were placed in 1.5-ml
tubes containing 100 μl diluted NP40 substitute assay reagent (supplied with the
kit). The samples were homogenized using a pestle, incubated at 70 °C for 5 min,
and then centrifuged for 10 min at 4 °C. To quantify TG content, 10 μl of each
sample was transferred to a 96-well plate and 150 μl of diluted enzyme mixture
solution (supplied with the kit) was added to each well. The plate was then
incubated for 15 min at room temperature, and the sample absorbances were
measured at a wavelength of 540 nm. To normalize lipid levels, protein levels were
measured from 10 μl of supernatant from each sample using the BCA assay kit, as
follows. The BCA solution was prepared by mixing solution A and solution B in a
ratio of 50:1. From each sample, 10 μl of supernatant were mixed with 200 μl of the
BCA solution, placed in a 96-well plate, and incubated at 37 °C for 30 min. The
absorbances were then measured at a wavelength of 562 nm to determine protein
levels. Finally, the normalized lipid level for each fly genotype was calculated by
dividing the OD value at 540 nm by the OD value at 562 nm.
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Statistical analysis. All experiments were performed at least three times
independently for each condition. The results of multiple experiments are
presented as the mean ± SEM. Statistical analyses were performed using Stu-
dent’s t-tests or analysis of variance (ANOVA) followed by Tukey’s multiple
comparison tests as appropriate; p < 0.05 was considered statistically significant.
Calculations were performed using GraphPad Prism5 (GraphPad Software, Inc.,
La Jolla, CA, USA).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1–10, Supplementary Figs. 1–19 and Supplementary
Tables 2 and 3 are provided as a Source Data file. All data are available from the
corresponding author upon reasonable request.
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